BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8331571)

  • 21. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
    Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
    Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries.
    Igase M; Okura T; Kitami Y; Hiwada K
    Clin Sci (Lond); 1999 Jun; 96(6):605-12. PubMed ID: 10334966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.
    Islam MM; Franco CD; Courtman DW; Bendeck MP
    Am J Pathol; 2003 Oct; 163(4):1557-66. PubMed ID: 14507662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization.
    Igarashi M; Takeda Y; Ishibashi N; Takahashi K; Mori S; Tominaga M; Saito Y
    Horm Metab Res; 1997 Sep; 29(9):444-9. PubMed ID: 9370113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha 1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury.
    Fingerle J; Sanders KH; Fotev Z
    Basic Res Cardiol; 1991; 86 Suppl 1():75-81. PubMed ID: 1674657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model.
    Lee S; Lim HJ; Park HY; Lee KS; Park JH; Jang Y
    Atherosclerosis; 2006 May; 186(1):29-37. PubMed ID: 16098530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067).
    Cohen ML; Parli CJ; Fuller RW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1006-11. PubMed ID: 2600800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral administration of the thrombin receptor antagonist E5555 (atopaxar) attenuates intimal thickening following balloon injury in rats.
    Kogushi M; Matsuoka T; Kuramochi H; Murakami K; Kawata T; Kimura A; Chiba K; Musha T; Suzuki S; Kawahara T; Kajiwara A; Hishinuma I
    Eur J Pharmacol; 2011 Sep; 666(1-3):158-64. PubMed ID: 21635884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of neointima formation with tissue-type plasminogen activator.
    Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
    J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury.
    Strawn WB; Ferrario CM; Tallant EA
    Hypertension; 1999 Jan; 33(1 Pt 2):207-11. PubMed ID: 9931106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical application of AT1 receptor antagonists prevents medial and neointimal proliferation after balloon injury.
    Taguchi J; Abe J; Ohno M; Schwartz SM; Kurokawa K
    Blood Press Suppl; 1994; 5():38-42. PubMed ID: 7889199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic suppression of intimal hyperplasia: a dose-response suppression by enalapril.
    Petrik PV; Law MM; Moore WS; Colburn MD; Quinones-Baldrich W; Gelabert HA
    Am Surg; 1995 Oct; 61(10):851-5. PubMed ID: 7668456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
    Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Horiuchi M; Katori R
    Blood Press Suppl; 1994; 5():43-8. PubMed ID: 7889200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of heparinoids on the sclerotic reaction of rat thoracic aorta to injury: comparison between standard and low-molecular-weight heparins in vitro and in vivo.
    Chajara A; Heudes D; Peronneau I; Jarnet J; Basset A; Capron L
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):995-1003. PubMed ID: 7523793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxazosin blocks the angiotensin II-induced smooth muscle cell DNA synthesis in the media, but not in the neointima of the rat carotid artery after balloon injury.
    van Kleef EM; Smits JF; Schwartz SM; Daemen MJ
    Cardiovasc Res; 1996 Feb; 31(2):324-30. PubMed ID: 8730410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hirulog-like peptide reduces balloon catheter injury induced neointima formation in rat carotid artery without increase in bleeding tendency.
    Xue M; Ren S; Welch S; Shen GX
    J Vasc Res; 2001; 38(2):144-52. PubMed ID: 11316950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological profile of a new 5-hydroxytryptamine2 receptor antagonist, DV-7028.
    Shibano T; Tanaka T; Morishima Y; Yasuoka M; Watanabe K; Fujii F
    Arch Int Pharmacodyn Ther; 1992; 319():114-28. PubMed ID: 1285670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.